4 active not recruiting. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 4 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Hypertriglyceridemia: new trials by email Literature Review of Hypertriglyceridemia trials Research Report on Hypertriglyceridemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RBD5044 in Chinese Participants With Hypertriglyceridemia RBD5044, Placebo - Hypertriglyceridemia | Phase 2 | Active not recruiting | Ribotek Biopharmaceuticals (Shandong) Co., Ltd | 40 | 2026-02-28 | 2026-08-24 |
| Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects RN0361 - Hypertriglyceridemia, Familial Chylomicronemia Syndrome | Phase 1 / Phase 2 | Active not recruiting | Ikaria Bioscience Pty Ltd | 108 | 2024-09-30 | 2025-12-30 |
| MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia MN-001, MN-001 placebo - Diabetes Mellitus, Type 2, Hypertriglyceridemia | Phase 2 | Active not recruiting | MediciNova | 40 | 2022-08-22 | 2026-02-05 |
| Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy Metreleptin - Diabetes, Lipodystrophy | Phase 2 | Active not recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 29 | 2014-10-14 | 2026-10-27 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Familial hyperchylomicronemia syndrome (1) · Hyperlipidemias (1) · Lipodystrophy (1) · Non-alcoholic Fatty Liver Disease (1)
Dyslipidemias (4) · Lipid Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Hyperlipidemias (3) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Diabetes Mellitus (1) · Digestive System Diseases (1) · Fatty Liver (1) · Liver Diseases (1) · Skin Diseases (1) · Skin Diseases, Metabolic (1) · Skin and Connective Tissue Diseases (1)
4-(6-acetyl-3-(3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyric acid (1) · metreleptin (1)
Ikaria Bioscience Pty Ltd (1) · MediciNova (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Ribotek Biopharmaceuticals (Shandong) Co., Ltd (1)
United States (3) · Australia (1) · China (1)